Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-20

Clinical Trial Update: Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of Posiformin 2% Eye Ointment for blepharitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Posiformin 2% Eye Ointment

Snippet

Sponsor: Ursapharm Arzneimittel GmbH | Conditions: Blepharitis, Signs and Symptoms | Phase 4 | Status: COMPLETED